|
FR2611501B1
(fr)
*
|
1987-03-04 |
1991-12-06 |
Corbiere Jerome |
Nouvelles compositions pharmaceutiques pour la voie buccale a base d'acetylsalielylate de lysine et leur procede d'obtention
|
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
|
JP3382159B2
(ja)
*
|
1998-08-05 |
2003-03-04 |
株式会社東芝 |
情報記録媒体とその再生方法及び記録方法
|
|
US6099862A
(en)
*
|
1998-08-31 |
2000-08-08 |
Andrx Corporation |
Oral dosage form for the controlled release of a biguanide and sulfonylurea
|
|
FR2796551B1
(fr)
*
|
1999-07-23 |
2003-07-25 |
Lipha |
Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
|
|
FR2796940B1
(fr)
*
|
1999-07-26 |
2005-04-08 |
Lipha |
Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
|
|
US20060034922A1
(en)
*
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
|
JP2004531463A
(ja)
|
2000-11-03 |
2004-10-14 |
アンドルクス ラブス，エルエルシー |
徐放メトホルミン組成物
|
|
AU2003241537A1
(en)
*
|
2002-05-23 |
2003-12-12 |
Andrx Corporation |
Biguanide formulations
|
|
ES2529180T3
(es)
|
2002-09-20 |
2015-02-17 |
Andrx Labs Llc |
Formulación multietapa que contiene una biguanida y un derivado de tiazolidinodiona
|
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
|
US20050048119A1
(en)
*
|
2002-09-20 |
2005-03-03 |
Avinash Nangia |
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
|
|
RU2006118801A
(ru)
*
|
2003-10-31 |
2007-12-10 |
Алза Корпорейшн (Us) |
Композиции и лекарственные формы для усиления всасывания габапентина и прегабалина
|
|
WO2008093984A1
(en)
|
2007-01-29 |
2008-08-07 |
Hanall Pharmaceutical Company. Ltd |
N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
|
|
JP5292404B2
(ja)
*
|
2007-09-21 |
2013-09-18 |
ハンオル バイオファーマ カンパニー，リミテッド |
Ｎ，ｎ−ジメチルイミドジカルボンイミド酸ジアミドのジカルボン酸塩、その製造方法、及びその薬剤学的組成物
|
|
JP5551691B2
(ja)
|
2008-06-26 |
2014-07-16 |
ラボラトリオス シラネス、エセ．ア．デ セ．べ． |
血糖制御のための新規グリシン酸メトホルミン塩
|
|
US20110021634A1
(en)
|
2009-06-18 |
2011-01-27 |
Patel Pranav Dushyant |
Processes for preparing metformin hydrochloride
|
|
WO2011049400A2
(ko)
*
|
2009-10-23 |
2011-04-28 |
한올바이오파마주식회사 |
N,n-디메틸 이미도디카르본이미딕 디아미드의 산 부가염을 포함하는 항암용 약제학적 조성물
|
|
CN101691344B
(zh)
*
|
2009-10-26 |
2012-10-17 |
漆又毛 |
一种二甲双胍酸式复盐化合物及制备方法
|
|
PT2576524T
(pt)
|
2010-05-26 |
2017-11-17 |
Vtv Therapeutics Llc |
Resumo
|
|
US8440723B2
(en)
*
|
2011-05-11 |
2013-05-14 |
Banavara L. Mylari |
Metformin salts of salicylic acid and its congeners
|
|
IN2014DN09554A
(enExample)
|
2012-05-17 |
2015-07-17 |
Transtech Pharma Llc |
|
|
US11510886B2
(en)
|
2016-09-30 |
2022-11-29 |
Laboratorios Silanes, S.A. De C.V. |
Metformin amino acid compounds and methods of using the same
|
|
MX2019003725A
(es)
|
2016-09-30 |
2019-08-12 |
Laboratorios Silanes S A De C V |
Glicinato de metformina, composiciones farmaceuticas que comprenden la misma, y metodos de uso de la misma.
|
|
CN107118130A
(zh)
*
|
2017-05-11 |
2017-09-01 |
杜剑平 |
一类治疗肿瘤的药物化合物及其应用
|
|
CA3093025A1
(en)
|
2018-06-12 |
2019-12-19 |
Vtv Therapeutics Llc |
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
|
|
US12391658B2
(en)
|
2020-02-18 |
2025-08-19 |
Vtv Therapeutics Llc |
Sulfoxide and sulfone glucokinase activators and methods of use thereof
|
|
CN115073331A
(zh)
*
|
2021-03-15 |
2022-09-20 |
中国医学科学院药物研究所 |
二甲双胍肉桂酸盐一水合物及制备方法和其组合物与用途
|